Correlation Between Memphis Pharmaceuticals and Al Arafa

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Memphis Pharmaceuticals and Al Arafa at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Memphis Pharmaceuticals and Al Arafa into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Memphis Pharmaceuticals and Al Arafa Investment, you can compare the effects of market volatilities on Memphis Pharmaceuticals and Al Arafa and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Memphis Pharmaceuticals with a short position of Al Arafa. Check out your portfolio center. Please also check ongoing floating volatility patterns of Memphis Pharmaceuticals and Al Arafa.

Diversification Opportunities for Memphis Pharmaceuticals and Al Arafa

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Memphis and AIVCB is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Memphis Pharmaceuticals and Al Arafa Investment in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Al Arafa Investment and Memphis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Memphis Pharmaceuticals are associated (or correlated) with Al Arafa. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Al Arafa Investment has no effect on the direction of Memphis Pharmaceuticals i.e., Memphis Pharmaceuticals and Al Arafa go up and down completely randomly.

Pair Corralation between Memphis Pharmaceuticals and Al Arafa

If you would invest  1,780  in Memphis Pharmaceuticals on September 23, 2024 and sell it today you would earn a total of  3,492  from holding Memphis Pharmaceuticals or generate 196.18% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy76.23%
ValuesDaily Returns

Memphis Pharmaceuticals  vs.  Al Arafa Investment

 Performance 
       Timeline  
Memphis Pharmaceuticals 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Memphis Pharmaceuticals are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile technical and fundamental indicators, Memphis Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.
Al Arafa Investment 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Al Arafa Investment has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Al Arafa is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Memphis Pharmaceuticals and Al Arafa Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Memphis Pharmaceuticals and Al Arafa

The main advantage of trading using opposite Memphis Pharmaceuticals and Al Arafa positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Memphis Pharmaceuticals position performs unexpectedly, Al Arafa can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Al Arafa will offset losses from the drop in Al Arafa's long position.
The idea behind Memphis Pharmaceuticals and Al Arafa Investment pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
CEOs Directory
Screen CEOs from public companies around the world